These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35984079)

  • 1. Cytokine Mixtures Mimicking the Local Milieu in Patients with Inflammatory Bowel Disease Impact Phenotype and Function of Mesenchymal Stromal Cells.
    Barnhoorn MC; van der Meulen-de Jong AE; Schrama ECLM; Plug LG; Verspaget HW; Fibbe WE; van Pel M; Hawinkels LJAC; Schepers K
    Stem Cells Transl Med; 2022 Sep; 11(9):932-945. PubMed ID: 35984079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.
    Ciccocioppo R; Cangemi GC; Kruzliak P; Gallia A; Betti E; Badulli C; Martinetti M; Cervio M; Pecci A; Bozzi V; Dionigi P; Visai L; Gurrado A; Alvisi C; Picone C; Monti M; Bernardo ME; Gobbi P; Corazza GR
    Stem Cell Res Ther; 2015 Jul; 6(1):137. PubMed ID: 26206376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of human adipose mesenchymal stem cells in Crohn's colon fibrosis is improved by IFN-γ and kynurenic acid priming through indoleamine 2,3-dioxygenase-1 signaling.
    Ye Y; Zhang X; Su D; Ren Y; Cheng F; Yao Y; Shi G; Ji Y; Chen S; Shi P; Dai L; Su X; Deng H
    Stem Cell Res Ther; 2022 Sep; 13(1):465. PubMed ID: 36076306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Mesenchymal Stem/Stromal Cell Therapy for Inflammatory Bowel Diseases: An Up-to-Date Systematic Review.
    Ko JZ; Johnson S; Dave M
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33440772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Intestinal Mesenchymal Stromal Cells From Patients With Inflammatory Bowel Disease for Autologous Cell Therapy.
    Anbazhagan M; Geem D; Venkateswaran S; Pelia R; Kolachala VL; Dodd A; Maddipatla SC; Cutler DJ; Matthews JD; Chinnadurai R; Kugathasan S
    Stem Cells Transl Med; 2023 Mar; 12(2):112-122. PubMed ID: 36869704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Crohn's disease mesenteric mesenchymal stem cells and their extracellular vesicles on T-cell immunosuppressive capacity.
    Dadgar N; Altemus J; Li Y; Lightner AL
    J Cell Mol Med; 2022 Oct; 26(19):4924-4939. PubMed ID: 36047483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
    Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
    Front Immunol; 2018; 9():1125. PubMed ID: 29910803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of Tissue-Resident Mesenchymal Stem Cells in Chronic Ulcerative Colitis and Crohn's Disease.
    Grim C; Noble R; Uribe G; Khanipov K; Johnson P; Koltun WA; Watts T; Fofanov Y; Yochum GS; Powell DW; Beswick EJ; Pinchuk IV
    J Crohns Colitis; 2021 Aug; 15(8):1362-1375. PubMed ID: 33506258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases.
    Che Z; Ye Z; Zhang X; Lin B; Yang W; Liang Y; Zeng J
    Front Immunol; 2022; 13():952071. PubMed ID: 35990688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
    Zimmermann JA; McDevitt TC
    Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases.
    Grégoire C; Lechanteur C; Briquet A; Baudoux É; Baron F; Louis E; Beguin Y
    Aliment Pharmacol Ther; 2017 Jan; 45(2):205-221. PubMed ID: 27878827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF-Overexpression and Pro-Inflammatory Priming in Human Mesenchymal Stromal Cells Improves the Healing Properties of Extracellular Vesicles in Experimental Crohn's Disease.
    Gómez-Ferrer M; Amaro-Prellezo E; Dorronsoro A; Sánchez-Sánchez R; Vicente Á; Cosín-Roger J; Barrachina MD; Baquero MC; Valencia J; Sepúlveda P
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
    Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
    Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis.
    Forte D; Ciciarello M; Valerii MC; De Fazio L; Cavazza E; Giordano R; Parazzi V; Lazzari L; Laureti S; Rizzello F; Cavo M; Curti A; Lemoli RM; Spisni E; Catani L
    Stem Cell Res Ther; 2015 Sep; 6(1):170. PubMed ID: 26353774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
    De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
    Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy.
    Saadh MJ; Mikhailova MV; Rasoolzadegan S; Falaki M; Akhavanfar R; Gonzáles JLA; Rigi A; Kiasari BA
    Eur J Med Res; 2023 Jan; 28(1):47. PubMed ID: 36707899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic Administration of Mesenchymal Stromal Cells Reduces Inflammation in Experimental Colitis.
    Barnhoorn M; de Jonge-Muller E; Molendijk I; van Gulijk M; Lebbink O; Janson S; Schoonderwoerd M; van der Helm D; van der Meulen-de Jong A; Hawinkels L; Verspaget H
    Inflamm Bowel Dis; 2018 Jul; 24(8):1755-1767. PubMed ID: 29796655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells.
    Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM
    Cytokine; 2016 Sep; 85():51-60. PubMed ID: 27288632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory effects of bone marrow-derived mesenchymal stem cells on pro-inflammatory cytokine-stimulated human corneal epithelial cells.
    Wen L; Zhu M; Madigan MC; You J; King NJ; Billson FA; McClellan K; Sutton G; Petsoglou C
    PLoS One; 2014; 9(7):e101841. PubMed ID: 25003339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.